Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Hepatic stellate cells contribute to progenitor cells and liver regeneration
Claus Kordes, Iris Sawitza, Silke Götze, Diran Herebian, Dieter Häussinger
Claus Kordes, Iris Sawitza, Silke Götze, Diran Herebian, Dieter Häussinger
View: Text | PDF
Research Article

Hepatic stellate cells contribute to progenitor cells and liver regeneration

  • Text
  • PDF
Abstract

Retinoid-storing hepatic stellate cells (HSCs) have recently been described as a liver-resident mesenchymal stem cell (MSC) population; however, it is not clear whether these cells contribute to liver regeneration or serve as a progenitor cell population with hepatobiliary characteristics. Here, we purified HSCs with retinoid-dependent fluorescence-activated cell sorting from eGFP-expressing rats and transplanted these GFP+ HSCs into wild-type (WT) rats that had undergone partial hepatectomy in the presence of 2-acetylaminofluorene (2AAF) or retrorsine, both of which are injury models that favor stem cell–based liver repair. Transplanted HSCs contributed to liver regeneration in host animals by forming mesenchymal tissue, progenitor cells, hepatocytes, and cholangiocytes and elevated direct bilirubin levels in blood sera of GUNN rats, indicating recovery from the hepatic bilirubin–handling defect in these animals. Transplanted HSCs engrafted within the bone marrow (BM) of host animals, and HSC-derived cells were isolated from BM and successfully retransplanted into new hosts with injured liver. Cultured HSCs transiently adopted an expression profile similar to that of progenitor cells during differentiation into bile acid–synthesizing and –transporting hepatocytes, suggesting that stellate cells represent a source of liver progenitor cells. This concept connects seemingly contradictory studies that favor either progenitor cells or MSCs as important players in stem cell–based liver regeneration.

Authors

Claus Kordes, Iris Sawitza, Silke Götze, Diran Herebian, Dieter Häussinger

×

Figure 8

Isolated HSCs form intermediate states of mesenchymal and epithelial cells during differentiation into hepatocyte-like cells.

Options: View larger image (or click on image) Download as PowerPoint
Isolated HSCs form intermediate states of mesenchymal and epithelial cel...
Combined immunofluorescence of (A) K19 and (B) α-fetoprotein as well as (C) LGR5 (red) with the mesodermal filament protein desmin (green) after treatment of primary HSC cultures with HGF and FGF4 for 14 days. Small cells with K19, α-fetoprotein, or LGR5 that coexpressed desmin are indicated with arrows. HSCs without growth factors (control) were also analyzed by immunofluorescence of (D) K19, (E) α-fetoprotein, or (F) LGR5 (red) in combination with desmin (green) after 14 days of culture. Hepatic differentiation of HSCs was analyzed by immunofluorescence of (G) BSEP, (H) NTCP, and (I) K18 (red) after 21 days of growth factor treatment. (G–L) To investigate the relationship of newly formed hepatocyte-like cells with HSCs, desmin residues were stained by immunofluorescence (green). (J) Transmission light microscopy and single immunofluorescence channels of (K) K18 (red) and (L) desmin (green) of the hepatocyte-like cell shown in I. Combined immunofluorescence analysis of (M) BSEP, (N) NTCP, and (O) K18 (red) with desmin (green) was also performed in HSCs cultured for 21 days without growth factor treatment (control).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts